Search clinical trials for: Ciprofloxacin and Valortim

Total 270321 results

PharmAthene, Inc.
Quintiles, Inc.; National Institutes of Health (NIH); Department of Health and... and other collaborators

Suspended

Ph1 Study of Valortim and Ciprofloxacin in Humans

Anthrax

United States
PharmAthene, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Completed

Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use

Allergic Reactions

United States
PharmAthene, Inc.
Quintiles, Inc.; National Institutes of Health (NIH); Department of Health and... and other collaborators

Terminated

Ph1 Study of Valortim and Doxycycline in Humans

Anthrax

United States
Poitiers University Hospital

Terminated

Short or Long Schemes of Antibiotic Prophylaxis for Prostate Biopsy

Men Who Must Undergo a Prostate Biopsy Related to Prostate Cancer Suspicion.

France
University of Florida

Terminated

Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)

Acute Myeloid Leukemia | Leukemia | Acute Myelogenous Leukemia

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis (COBRA)

Cholangitis

Netherlands
Bayer

Completed

BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis

Bacterial Infections

United States, Spain, Italy, Canada, Brazil, Mexico
Guohua Zeng

Unknown

Comparison of Multiple-, Single- and Zero-dose of Ciprofloxacin Prophylaxis in Retrograde Intrarenal Surgery (RIRS)

Kidney Stones

China
MerLion Pharmaceuticals GmbH

Completed

Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis

Urinary Tract Infections | Acute Pyelonephritis

Germany
Otonomy, Inc.

Completed

Dose Ranging Study of OTO-201 in AOMT

Acute Otitis Media | AOMT

United States
Bayer

Completed

Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections (EMERON)

Urinary Tract Infection

Italy
Kaiser Permanente

Completed

A Pilot Study on the Use of Prophylactic Antibiotics for EUS-guided Pancreatic Cyst Aspiration

Pancreatic Cysts

United States
Otic Pharma

Completed

Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa

Otorhinolaryngologic Diseases | Ear Diseases | Otitis Externa | Otitis

Israel
Facultad Nacional de Salud Publica
Universidad de Antioquia

Completed

Comparison of Moxifloxacin With Ciprofloxacin/Metronidazole on Patients With Chronic Periodontitis

Chronic Periodontitis

Colombia
Mount Sinai Hospital, Canada
Crohn's and Colitis Foundation

Terminated

Study of Antibiotics in the Treatment of Colonic Crohn's Disease

Crohn's Disease

Canada
Aradigm Corporation
Grifols Therapeutics LLC

Completed

Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)

Non Cystic Fibrosis Bronchiectasis

United States, Italy, Poland, Taiwan, United Kingdom, Germany, Spain, Israel, Romania, South Africa, Korea, Republic of, Australia, Canada, Hungary, Ireland, Latvia
Mansoura University

Completed

A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy

Benign Prostate Hyperplasia

Egypt
Tedec-Meiji Farma, S.A.

Completed

Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis

Urinary Tract Infections

Spain, Greece
Indiana University School of Medicine

Completed

Penetrance of Third Generation Fluoroquinolones in Eyes With Functioning Filtering Blebs

Cataract

United States
Assistance Publique - Hôpitaux de Paris

Terminated

Parameters Associated With the Emergence of Resistance to Ciprofloxacin in Human Commensal Flora

Healthy Volunteers

France
University of Maryland, Baltimore
Food and Drug Administration (FDA)

Completed

Impact of Formulation on Ciprofloxacin Oral Absorption

Healthy

United States
Centers for Disease Control and Prevention
MRC/UVRI and LSHTM Uganda Research Unit; Ministry of Health, Uganda

Unknown

A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans

Plague

Uganda
Mazandaran University of Medical Sciences

Completed

Ciprofloxacin in Drug-resistant Epilepsy (CIDRE)

Epilepsy Intractable

Iran, Islamic Republic of
Bayer

Completed

Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution

Infection

Japan
Damanhour University

Completed

Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting

Ciprofloxacin Adverse Reaction

Egypt
Bayer

Completed

Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance

Infection

Japan
Bayer

Completed

Ciprofloxacin on Burned Patients

Burns | Bacterial Infections

Italy
Federal University of São Paulo

Terminated

Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery

Inflammation | Bacterial Infections

Brazil
Otonomy, Inc.

Completed

OTO-201 for the Treatment of Otitis Externa

Otitis Externa

United States
Universitaire Ziekenhuizen KU Leuven

Completed

Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis (CCTOBI)

Cystic Fibrosis

Belgium
Bayer
Novartis

Completed

Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

Bronchiectasis | Pulmonary Disease, Chronic Obstructive

United States
Bayer

Completed

To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD, GOLD II-III)

Pulmonary Disease, Chronic Obstructive

Japan
Bayer

Completed

Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens

Urinary Tract Infections

United States
University Hospital, Ghent
Universitair Ziekenhuis Brussel

Completed

Pharmacokinetics of Ciprofloxacin in Pediatric Patients

Urinary Tract Infection | Pyelonephritis

Belgium
Bayer

Completed

Special Drug Use Investigation of Ciproxan Injection in Pediatrics

Cystitis / Pyelonephritis / Cystic Fibrosis / Anthrax

Japan
Bayer

Completed

Cipro Inhaler for Cystic Fibrosis Children Ages 6-12

Pseudomonas Infection

United States
University of Washington

Recruiting

SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection

Neisseria Gonorrhoeae Infection

United States
GlaxoSmithKline
Parexel

Completed

Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects

Infections, Bacterial

South Africa
Center for Supporting Hematology-Oncology Trials
Bayer

Completed

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases

Febrile Neutropenia

Japan
Aradigm Corporation

Completed

Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"

Non-Cystic Fibrosis Bronchiectasis

United States, Germany, Canada, United Kingdom
Korea University
Kyungpook National University Hospital; Soon Chun Hyang University; Sungkyunkwan...

Completed

Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention

Adverse Reaction to Other Drugs and Medicines

Korea, Republic of
Lawson Health Research Institute
The Physicians' Services Incorporated Foundation

Terminated

Efficacy of Antimicrobial Prophylaxis for Shock Wave Lithotripsy (SWL) on Reducing Urinary Tract Infection (UTI)

Urolithiasis

Canada
Bayer
Novartis

Completed

Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis

Cystic Fibrosis

United States, Israel, Germany, Canada, Australia, Sweden, Denmark, Norway, United Kingdom
Bayer

Completed

Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder

Pulmonary Disease, Chronic Obstructive | Infection

Germany
Aradigm Corporation
Grifols Therapeutics LLC

Completed

Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)

Non Cystic Fibrosis Bronchiectasis

United States, Italy, Poland, United Kingdom, France, Spain, Israel, Romania, Korea, Republic of, Australia, Canada, New Zealand, Hungary, Georgia, Former Serbia and Montenegro, Peru
Otonomy, Inc.

Completed

Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes

Otitis Media

United States
Johns Hopkins University

Terminated

Impact of Antibiotic Treatment on Prostate-Specific Antigen (PSA) Variability

Prostate Infections

United States
Leiden University Medical Center
Medical Center Haaglanden; Rijnland Hospital; Groene Hart Ziekenhuis; Spaarne Gasthuis and other collaborators

Completed

Febrile Urinary Tract Infection Randomized Short Treatment Trial (FUTIRST)

Urinary Tract Infection

Netherlands
Bayer

Completed

A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia

Pneumonia

Japan
Bayer

Completed

A Phase IV Study of Cipro XR in Uncomplicated UTI (EXPRESS)

Urinary Tract Infections

Search clinical trials for: Ciprofloxacin and Valortim

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations